乐观
$22.20
情景价格
$16.660
+0.327 (+1.96%)收盘时
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others.
Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.
UBS
—
2026-09-01
UBS
2026-09-01
目标价
—
Ladenburg
$20
2026-07-31
Ladenburg
2026-07-31
目标价
$20
UBS
$15
2026-05-18
UBS
2026-05-18
目标价
$15
Ladenburg
$21
2026-05-06
Ladenburg
2026-05-06
目标价
$21
Piper Sandler
$17
2026-05-06
Piper Sandler
2026-05-06
目标价
$17
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Hercules Capital Secures Fitch BBB Rating Affirmation

Hercules Capital Closes $400 Million Note Offering

Rocket Pharmaceuticals Secures $150 Million Credit Facility

Hercules Capital Announces $400 Million Note Offering

Hercules Capital Raises $2.3 Billion in New Equity Commitments
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others. It operates in the Financials sector.
Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.
11 analysts cover HTGC: 7 rate it Buy, 4 Hold and 0 Sell. The average price target is 20.04.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。